While initially approved for managing blood sugar in Type 2 Diabetes , blocking the SGLT2 transporter has shown "unexpected" advantages for the heart and kidneys:
: By reducing the pressure within the kidney filters (glomeruli), they slow the progression of Chronic Kidney Disease (CKD) .
"Transporter 2" received generally positive reviews from critics, with many praising the film's action sequences and Jason Statham's performance. The movie was a commercial success, grossing over $77 million worldwide. transportador 2
The (SGLT2) is a protein located in the early part of the kidney's proximal tubule. Its primary biological function is the reabsorption of glucose from the urine back into the bloodstream.
One of the key themes of "Transporter 2" is the performance of identity. Frank Martin's character is defined by his professionalism and expertise as a transporter. He is a man of few words, preferring to let his actions speak louder than his words. Through his interactions with Kim and other characters, Frank's identity is revealed as a complex mix of toughness, vulnerability, and empathy. While initially approved for managing blood sugar in
"Transportador 2" is likely a reference to the movie "The Transporter 2" or "Transporter 2", which is an action film directed by Louis-Julien Petit and released in 2005. It is the sequel to the 2002 film "The Transporter".
The film also explores the theme of surveillance and monitoring. Frank is constantly being tracked and monitored by Murphy's operatives, who use advanced technology to try and capture him. This theme is echoed in Frank's use of technology to stay one step ahead of his pursuers. The (SGLT2) is a protein located in the
: It works by coupling the transport of sodium with glucose, moving both substances across the cell membrane against a glucose concentration gradient.